MARC details
000 -LEADER |
fixed length control field |
02888cas a2200505 a 4500 |
001 - CONTROL NUMBER |
control field |
11438084 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20230905135631.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
940121c19949999pauar f 0 a0eng c |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
94644516 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781573401760 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1573401765 |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1074-2816 |
ISSN-L |
1074-2816 |
Source |
1 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
BUL |
Language of cataloging |
eng |
Transcribing agency |
BUL |
Modifying agency |
BUL |
Description conventions |
rda |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QZ 267 K598c 2001 |
Item number |
K598c 2001 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.99406 |
Edition number |
20 |
Item number |
KIR |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
Kirkwood, John M. |
210 0# - ABBREVIATED TITLE |
Abbreviated title |
Curr. cancer ther. |
222 #0 - KEY TITLE |
Key title |
Current cancer therapeutics |
245 00 - TITLE STATEMENT |
Title |
Current cancer therapeutics / |
Statement of responsibility, etc. |
John M. Kirkwood, Michael T. Lotze, Joyce M. Yasko |
250 ## - EDITION STATEMENT |
Edition statement |
4th edition |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Philadelphia, PA : |
Name of publisher, distributor, etc. |
Current Medicine, |
Date of publication, distribution, etc. |
©1994- |
300 ## - PHYSICAL DESCRIPTION |
Extent |
volumes : |
Other physical details |
ill. ; |
Dimensions |
28 cm |
310 ## - CURRENT PUBLICATION FREQUENCY |
Current publication frequency |
Annual |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Media type code |
n |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Carrier type code |
nc |
Source |
rdacarrier |
362 0# - DATES OF PUBLICATION AND/OR SEQUENTIAL DESIGNATION |
Dates of publication and/or sequential designation |
1st ed.- |
505 ## - FORMATTED CONTENTS NOTE |
Formatted contents note |
Contents <br/>1: Agents.<br/> 1. Alkylating and Platinating Agents.<br/> 2. Antimetabolic Agents.<br/> 3. Biologic Agents.<br/> 4. Hormonal Agents.<br/> 5. Tubulin-Targeting Drugs <br/><br/>2: Specific Neoplasms and Therapeutic Protocols.<br/> 6. Breast Cancer.<br/> 7. Upper Gastrointestinal Cancer.<br/> 8. Lower Gastrointestinal Cancer.<br/> 9. Head and Neck Cancer.<br/>10. Lung Cancer.<br/> 11. Melanoma and Other Tumors of the Skin.<br/> 12. Sarcomas.<br/> 13. Genitourinary Cancer.<br/> 14. Gynecologic Malignancies.<br/> 15. Malignant Glioma.<br/> 16. Endocrine Cancer.<br/> 17. Leukemia.<br/> 18. Hodgkin's Disease.<br/> 19. Non-Hodgkin's Lymphoma.<br/> 20. Myeloma.<br/> 21. Malignant Effusions in the Chest.<br/> 22. Carcinoma of Unknown Primary.<br/> 23. Aids-Related Malignancies. <br/><br/>3: Supportive Care.<br/> 24. Palliative Care.<br/> 25. Myelosuppression.<br/> 26. Gastrointestinal Toxicities.<br/> 27. Renal and Metabolic Complications.<br/> 28. Pulmonary and Cardiovascular Complications of Cancer Therapy.<br/> 29. Neurotoxicities.<br/> 30. Evaluation of Quality of Life in Cancer Clinical Trials.<br/> 31. Systemic Manifestations of Cancer and Management of Systemic Paraneoplastic Syndromes.<br/> 32. Malnutrition.<br/><br/>4: Clinical Trial Data Collection.<br/> 33. Clinical Trials: Monitoring and Reporting of Toxicities, and Evaluating Tumor Response.<br/> 34. Synoptic Pathology Reports.<br/> |
590 ## - LOCAL NOTE (RLIN) |
Local note |
SERBIB/SERLOC merged record |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cancer |
General subdivision |
Treatment |
Form subdivision |
Periodicals. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Neoplasms |
General subdivision |
therapy. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Antineoplastic Agents |
General subdivision |
therapeutic use. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cancer |
General subdivision |
Treatment. |
Source of heading or term |
fast |
655 #2 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Handbook. |
655 #7 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Periodicals. |
Source of term |
fast |
655 #7 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Periodicals. |
Source of term |
lcgft |
700 ## - ADDED ENTRY--PERSONAL NAME |
Personal name |
Lotze, Michael T. |
700 ## - ADDED ENTRY--PERSONAL NAME |
Personal name |
Yasko, Joyce M. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Online version: |
Title |
Current cancer therapeutics |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Book Open Access |
Edition |
4th edition |
Classification part |
QZ 267 K598c 2001 |
Item part |
1 |
Call number prefix |
QZ 267 |
Call number suffix |
K598c 2001 |